ClinicalTrials.govpublic full text
Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease
intermittent fasting, metabolic dysfunction-associated fatty liver disease, fibroblast growth factor 21, autophagy, fatty liver, time-restricted eating, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847295
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.